Price is set for Avastin
Title: FDA Approves Genentech's Avastin Colon Cancer Medicine
Source: LA Times
Date: February 27, 2004
From the article:
- At a cost of $4,400 a month, Avastin would also be one of the most expensive cancer treatments available, analysts said. The addition of Avastin to standard chemotherapy would raise the annual cost of treatment to $60,000 to $80,000.
- The price set for Avastin is more than double the predictions for the drug on Wall Street, which ranged from $1,500 to $2,000 a month.
Ian Clark, general manager of Genentech's cancer drug business, said the price reflects the value the drug provides to patients including "a significant survival benefit."
"We feel the price we fixed is a fair one and we think customers will see it that way," Clark said.